Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Lionsgate Studios stock today: LION slides after insider sale filings hit the tape

Lionsgate Studios stock today: LION slides after insider sale filings hit the tape

NEW YORK, December 31, 2025, 12:52 ET — Regular session Shares of Lionsgate Studios Corp fell 3.4% to $8.94 in midday trading on Wednesday after regulatory filings disclosed stock sales by two top executives. The stock opened at $9.16 and traded between $8.94 and $9.16, with about 1.23 million shares changing hands. The move matters because the studio’s shares have been trading near yearly highs, leaving less cushion for negative headlines. Insider sales are routine, but they can act as a trigger for profit-taking when a stock has rallied and investors are hunting for the next catalyst. The disclosures also
Why Rush Street Interactive (RSI) stock is down today: Zacks downgrade to “hold”

Why Rush Street Interactive (RSI) stock is down today: Zacks downgrade to “hold”

NEW YORK, December 31, 2025, 12:46 ET — Regular session. Rush Street Interactive, Inc. shares were down 3.6% on Wednesday after Zacks Research downgraded the online-gambling operator to “hold,” MarketBeat reported. The stock was down 72.5 cents at $19.39 by 12:46 p.m. ET after trading between $19.36 and $20.27, on about 318,000 shares. MarketBeat said the stock still carries a “Moderate Buy” consensus rating and an average target price of $21.25, and pegged its market value at about $4.6 billion. MarketBeat The drop matters because RSI has been one of the smaller, faster-growing names tied to the spread of regulated
31 December 2025
JFrog stock falls about 3% today as year-end tech dip hits software names

JFrog stock falls about 3% today as year-end tech dip hits software names

NEW YORK, December 31, 2025, 12:50 ET — Regular session JFrog Ltd (FROG.O) shares fell 3.2% to $63.35 by midday in New York, after opening at $65.24 and hitting an intraday low of $62.72. The stock was trading in a $62.72 to $65.53 range. The move came as U.S. equities drifted lower in holiday-thinned trading on the final session of 2025, with technology stocks among the heavier weights. “Describing 2025 as ‘resilient’ might be an understatement,” Adam Turnquist, chief technical strategist at LPL Financial, said. Reuters Benchmark ETFs tracking the S&P 500 and Nasdaq were both modestly lower, underscoring a
Cogent Biosciences (COGT) stock slips as insider sales follow bezuclastinib FDA filing

Cogent Biosciences (COGT) stock slips as insider sales follow bezuclastinib FDA filing

NEW YORK, December 31, 2025, 11:55 ET — Regular session Shares of Cogent Biosciences slid on Wednesday, paring losses from earlier in the session, after the biotech disclosed a key regulatory filing while investors digested a cluster of insider stock sales. The stock was down 2.5% at $36.19, after touching a low of $34.33. The move comes as Cogent shifts from late-stage data to the U.S. Food and Drug Administration review process — a step that can widen the audience beyond biotech specialists and pull more short-term traders into the name. A New Drug Application, or NDA, is the formal
AAON stock slips even after credit line boost to $600 million — what Wall Street is watching next

AAON stock slips even after credit line boost to $600 million — what Wall Street is watching next

NEW YORK, Dec 31, 2025, 12:20 ET — Regular session. AAON shares were down 2.7% at $76.48 in midday trade on Wednesday, after touching $79.67 earlier in the session. The move came two days after AAON disclosed it increased borrowing capacity on its existing credit facility to $600 million by exercising a previously available $100 million “accordion” feature — an option that lets borrowers expand a credit line under agreed terms. SEC Why it matters now: credit capacity tends to draw scrutiny when rates are still elevated and investors are quick to punish any sign that cash needs are rising
31 December 2025
BKV stock slides as natural gas tumbles again — what traders are watching next

BKV stock slides as natural gas tumbles again — what traders are watching next

NEW YORK, December 31, 2025, 12:25 PM ET — Regular session BKV Corp shares slipped on Wednesday as the latest leg lower in U.S. natural gas prices weighed on sentiment across gas-linked producers. The stock was down about 2.6% at around $27.10 in midday trading, after touching $27.00. Why it matters now: natural gas has been driving the near-term tape for U.S. gas-heavy names, and the commodity moved sharply again into year-end. Henry Hub futures were last indicated down roughly 4.5% on the day, according to CME pricing. CME Group That kind of swing can quickly reset expectations for cash
LandBridge stock hits fresh 52-week low as oil heads for biggest annual drop since 2020

LandBridge stock hits fresh 52-week low as oil heads for biggest annual drop since 2020

NEW YORK, Dec 31, 2025, 12:13 ET — Regular session LandBridge Company LLC shares slid on Wednesday and briefly set a new 52-week low, extending a late-year pullback as investors weighed a weaker crude backdrop and a risk-off tone in energy-linked pockets of the market. Investing.com The stock was down 3.2% at $48.63 in midday trading, after touching an intraday low of $48.29 — below the prior 52-week floor flagged in market reports. Investing.com+1 The move matters now because LandBridge’s business is tied to activity in the Permian Basin through surface and related revenue streams, leaving sentiment sensitive to the
31 December 2025
Xometry stock slides about 3.5% in year-end trade; what XMTR investors are watching next

Xometry stock slides about 3.5% in year-end trade; what XMTR investors are watching next

NEW YORK, December 31, 2025, 11:38 ET — Regular session Shares of Xometry Inc fell about 3.5% to $60.94 in midday trading on Wednesday, after closing at $63.14 in the prior session. The Nasdaq-listed stock traded as high as $63.94 and as low as $60.58. The drop outpaced a modest retreat in U.S. equities on the final trading day of 2025, with broad indexes edging lower in thin holiday liquidity ahead of markets’ New Year’s Day closure. Reuters Year-end repositioning has been a focus for investors as 2026 approaches. “It’s just a healthy rebalancing of allocations,” Mark Hackett, chief market
MIAX slides as year-end trading thins — what traders are watching next

MIAX slides as year-end trading thins — what traders are watching next

NEW YORK, December 31, 2025, 12:19 ET — Regular session. Miami International Holdings, Inc. shares were down 2.2% on Wednesday midday, a softer tape in thin, year-end trading for the exchange operator. The stock last traded at $44.70, down $0.99 from the previous close, after moving between $44.05 and $46.00 in the session. (https://www.marketwatch.com/investing/stock/miax) MarketWatch Why it matters now: MIAX has become a closely watched “picks-and-shovels” bet on derivatives activity — and into the final sessions of the year, investors often focus less on new headlines and more on positioning, liquidity and supply-demand shifts in recently listed names. Reuters There
31 December 2025
Regencell Bioscience (RGC) stock slides nearly 5% in year-end trading as volatility persists

Regencell Bioscience (RGC) stock slides nearly 5% in year-end trading as volatility persists

NEW YORK, December 31, 2025, 11:51 ET — Regular session Regencell Bioscience Holdings Limited shares were down 4.8% at $21.79 as of 11:51 a.m. ET, after trading between $21.44 and $23.11 in a choppy session. The move came without any new company announcements. Regencell’s investor-relations site lists its most recent press release dated Oct. 31, and the latest SEC filing on EDGAR is its annual report filed the same day. Regencell Bioscience -+1 The pullback also tracked a softer tape across Wall Street on the final trading day of 2025, with trading volumes muted heading into the New Year’s holiday.
31 December 2025
Genmab stock slides today as GMAB shelves acasunlimab; Merus takeout steps in focus

Genmab stock slides today as GMAB shelves acasunlimab; Merus takeout steps in focus

NEW YORK, December 31, 2025, 11:38 ET — Regular session Genmab A/S (GMAB) shares slid on Wednesday, down about 3.3% at $30.44 in New York trading, as investors weighed a late-stage pipeline cut and the closing steps of a major acquisition. The Nasdaq-listed ADR touched $30.36 after opening at $31.42. Genmab said on Dec. 29 it will discontinue further clinical development of acasunlimab following a portfolio review and said the move does not change its full-year 2025 financial guidance. “Although the data have been encouraging, the compelling opportunities we see in our late‑stage pipeline led us to focus our investments,”
Abivax stock drops today as ABVX traders trim Eli Lilly takeover bets into year-end

Abivax stock drops today as ABVX traders trim Eli Lilly takeover bets into year-end

NEW YORK, December 31, 2025, 11:19 ET — Regular session Abivax Société Anonyme’s U.S.-listed American depositary shares (ABVX) fell about 3.8% to $133.04, down roughly $5.30 from Tuesday’s close, in late morning trade on Wednesday. The shares opened at $138 and swung between $132.13 and $140.25, with about 348,000 shares traded. The pullback keeps the spotlight on ABVX after takeover chatter earlier this month. Reuters reported on Dec. 10 that Abivax jumped on market rumours that Eli Lilly could make an offer, and Stifel analyst Damien Choplain said the “share price movement is driven by speculation around a possible takeover.”
Nasdaq Keeps PLTS Trading Halted With No Reason Listed as Bengaluru ‘My Room, My Rules’ Row Spreads Online

Nasdaq Keeps PLTS Trading Halted With No Reason Listed as Bengaluru ‘My Room, My Rules’ Row Spreads Online

NEW YORK, December 31, 2025, 11:28 ET Nasdaq kept trading in Platinum Analytics Cayman Limited (PLTS) halted on Wednesday, with the reason listed as “not available” as of 10:23 a.m. ET, according to a Reuters market notice. TradingView The halt matters because it prevents investors from buying or selling the shares while they wait for clarity, a bigger issue in thin year-end trading when price swings can be sharper once a stock reopens. Nasdaq normally assigns a code when it pauses trading — including “news pending,” used when material news is expected, and “additional information requested,” which can follow a
31 December 2025
Why Life360 stock is sliding today as year-end trading hits tech names

Why Life360 stock is sliding today as year-end trading hits tech names

NEW YORK, December 31, 2025, 11:12 ET — Regular session Life360, Inc. shares were down 4.4% at $63.79 in morning trading, after moving between $63.79 and $67.05. The Nasdaq-listed stock was off $2.94 from Tuesday’s close and had traded about 108,000 shares. The move comes as investors close the books on the final trading day of 2025, a stretch that often brings thinner liquidity and sharper price swings in smaller growth stocks. Wall Street’s major indexes were slightly lower and tech stocks extended losses as markets looked ahead to the path of U.S. interest rates into 2026. “The economy showed
PSLV stock today: Sprott Physical Silver Trust slides as silver retreats — what investors are watching

PSLV stock today: Sprott Physical Silver Trust slides as silver retreats — what investors are watching

NEW YORK, December 31, 2025, 11:08 ET — Regular session Sprott Physical Silver Trust (PSLV) slid 4.3% to $24.14 in Wednesday trading, tracking a renewed drop in silver prices after a record-setting run. The move matters because PSLV is one of the most heavily traded, exchange-listed ways to get exposure to physical silver, making it a quick read on sentiment when the metal turns volatile. Spot silver was down about 5% near $73 an ounce after hitting a record $83.62 on Monday, and it is up more than 150% year-to-date, Reuters reported. “The short-term is very choppy … but we
XPeng stock slides 6% today as Chinese EV shares retreat in thin year-end trade

XPeng stock slides 6% today as Chinese EV shares retreat in thin year-end trade

NEW YORK, December 31, 2025, 11:11 ET — Regular session XPeng Inc’s U.S.-listed shares slid about 6% on Wednesday, down 6.0% at $19.99 by 11:11 a.m. ET. The late-year session often brings thinner liquidity, which can magnify moves in higher-risk names. For investors in Chinese EVs, the timing matters because fresh demand signals arrive in early January, when manufacturers typically publish monthly delivery figures and China rolls out updated consumer incentives. XPeng’s ADRs (American depositary receipts, the U.S.-traded version of its shares) opened at $20.50 and hit a low of $19.87 before paring losses. The stock traded as high as
Applied Digital’s ChronoScale plan: Cloud spin-off and Ekso tie-up puts AI GPUs in focus

Applied Digital’s ChronoScale plan: Cloud spin-off and Ekso tie-up puts AI GPUs in focus

NEW YORK, December 31, 2025, 10:43 ET Applied Digital said it plans to spin out its cloud computing business and combine it with Ekso Bionics to form ChronoScale, a new platform built around graphics processing units (GPUs) used to run artificial intelligence workloads. Applied Digital shares were up about 2.4% at $24.65 in morning trading. Applied Digital Corporation The proposed deal lands as demand for dedicated AI computing capacity pushes companies to secure scarce GPU supply. GPUs are specialized chips that speed up AI training and “inference,” the process of running models after they are built. Investors have also tended
ICL stock rises about 3% as fertilizer prices cool — what investors are watching next

ICL stock rises about 3% as fertilizer prices cool — what investors are watching next

NEW YORK, December 31, 2025, 11:00 ET — Regular session ICL Group Ltd shares were up about 3.4% at $5.73 in morning trading on Wednesday, after touching $5.75 at the session high. The stock opened at $5.53 and traded as low as $5.55, with about 1.2 million shares changing hands. The move lands as investors gauge pricing signals for crop nutrients heading into 2026, after a late-December pullback in retail fertilizer prices. DTN said seven of eight major fertilizers it tracks were lower in the fourth week of December, including diammonium phosphate (DAP) — a common phosphate fertilizer — down
31 December 2025
Via Transportation stock rises today as VIA trims post-IPO slump in New York trade

Via Transportation stock rises today as VIA trims post-IPO slump in New York trade

NEW YORK, December 31, 2025, 10:45 ET — Regular session Shares of Via Transportation Inc climbed about 3% to $30.38 by late morning on Wednesday, after trading as low as $29.40 and as high as $30.51. About 110,000 shares had changed hands. The bounce matters because Via is still in the early months of life as a public company, when liquidity and valuation can swing sharply on small shifts in sentiment. Investors are also trying to map a contract-heavy public transit business onto a quarterly earnings calendar. Via sells software that helps transit agencies and cities run on-demand shuttles and
31 December 2025
Why TeraWulf (WULF) stock is up today: KBW upgrade flags AI leasing pivot and $1.3B Texas financing

Why TeraWulf (WULF) stock is up today: KBW upgrade flags AI leasing pivot and $1.3B Texas financing

NEW YORK, December 31, 2025, 10:44 ET — Regular session Shares of TeraWulf Inc rose about 4.4% to $11.64 in morning trading on Wednesday after Keefe, Bruyette & Woods upgraded the stock to Outperform and raised its price target to $24 from $9.50. TipRanks The call matters because crypto miners are increasingly being valued as power-and-real-estate plays, not just bets on bitcoin prices. Investors have been looking for steadier revenue streams as bitcoin mining margins swing with token prices, network difficulty and electricity costs. TeraWulf has been pushing deeper into renting out data-center capacity to customers running artificial intelligence workloads,
1 282 283 284 285 286 535

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Go toTop